Table 3.
Early treatment group (n=149) | Deferred treatment group (n=150) | |
---|---|---|
CDC category C events | ||
Incidence per 1000 patient-years | 7·6 (2·5–23·6) | 4·9 (1·2–19·7) |
Number of children | 3 | 2 (1, 1) |
Pneumocystis jirovecii pneumonia | 1 | 0 |
Disseminated penicilliosis | 1 | 0 |
Severe sepsis | 1 | 0 |
Oesophageal candidiasis | 0 | 1 (1, 0) |
Extrapulmonary tuberculosis | 0 | 1 (0, 1) |
CDC category B events | ||
Incidence per 1000 patient-years | 88 (61–122) | 110 (80–147) |
Number of children | 20 | 32 |
Number of events | 35 | 45 (34, 11) |
Bacterial pneumonia | 16 | 9 (7, 2) |
Lymphoid interstitial pneumonia | 9 | 0 |
Thrombocytopenia | 1 | 10 (10, 0) |
Herpes zoster | 2 | 13 (9, 4) |
Herpes simplex | 1 | 6 (4, 2) |
Complicated chickenpox | 1 | 1 (1, 0) |
Pulmonary tuberculosis | 1 | 1 (1, 0) |
Oral candidiasis | 2 | 3 (1, 2) |
Diarrhoea | 1 | 2 (1, 1) |
Molluscum contagiosum | 1 | 0 |
Hospital admissions | ||
Incidence per 1000 patient-years | 123 (91–163) | 88 (62–122) |
Number of admissions | 49 | 36 |
HIV related* | 14 | 11 |
Antiretroviral adverse drug reactions | 7 | 2 |
Not HIV related | 28 | 23 |
Data are incidence (95% CI), n, or n (events before antiretroviral therapy, events after antiretroviral therapy). CDC=US Centers for Disease Control and Prevention.
One child in the early treatment group had six admissions for pneumonia, and subsequently died.